These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23370347)

  • 1. Therapeutic application of stem cell technology toward the treatment of Parkinson's disease.
    Nishimura K; Takahashi J
    Biol Pharm Bull; 2013; 36(2):171-5. PubMed ID: 23370347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
    Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O
    Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial.
    Studer L
    Prog Brain Res; 2017; 230():191-212. PubMed ID: 28552229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical translation of stem cell transplantation in Parkinson's disease.
    Lindvall O
    J Intern Med; 2016 Jan; 279(1):30-40. PubMed ID: 26332959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redefining Parkinson's disease research using induced pluripotent stem cells.
    Pu J; Jiang H; Zhang B; Feng J
    Curr Neurol Neurosci Rep; 2012 Aug; 12(4):392-8. PubMed ID: 22622410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell therapies for Parkinson's disease: are trials just around the corner?
    Drouin-Ouellet J; Barker RA
    Regen Med; 2014; 9(5):553-5. PubMed ID: 25372072
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopaminergic differentiation using pluripotent stem cells.
    Momčilović O; Montoya-Sack J; Zeng X
    J Cell Biochem; 2012 Dec; 113(12):3610-9. PubMed ID: 22807388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiently Specified Ventral Midbrain Dopamine Neurons from Human Pluripotent Stem Cells Under Xeno-Free Conditions Restore Motor Deficits in Parkinsonian Rodents.
    Niclis JC; Gantner CW; Alsanie WF; McDougall SJ; Bye CR; Elefanty AG; Stanley EG; Haynes JM; Pouton CW; Thompson LH; Parish CL
    Stem Cells Transl Med; 2017 Mar; 6(3):937-948. PubMed ID: 28297587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
    Cooper O; Parmar M; Isacson O
    Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced dopaminergic neurons: A new promise for Parkinson's disease.
    Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
    Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges.
    Xiao B; Ng HH; Takahashi R; Tan EK
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):697-702. PubMed ID: 26833176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From stem cells to dopamine neurons: developmental biology meets neurodegeneration.
    Tailor J; Andreska T; Kittappa R
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):893-6. PubMed ID: 23131155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells.
    Stoddard-Bennett T; Reijo Pera R
    Cells; 2019 Jan; 8(1):. PubMed ID: 30621042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
    Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
    Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluripotent stem cells for Parkinson's disease: progress and challenges.
    Zeng X; Couture LA
    Stem Cell Res Ther; 2013 Apr; 4(2):25. PubMed ID: 23672848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization, and banking of clinical-grade cells for neural transplantation: Scale up, fingerprinting, and genomic stability of stem cell lines.
    Natalwala A; Kunath T
    Prog Brain Res; 2017; 230():133-150. PubMed ID: 28552226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).
    Kirkeby A; Parmar M; Barker RA
    Prog Brain Res; 2017; 230():165-190. PubMed ID: 28552228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.